Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed)
This grant opportunity is focused on funding research that explores how changes in immune system metabolism caused by HIV impact the regulation of immune cells, their interactions, responses to treatments, and the progression of tuberculosis (TB) and hepatitis B (HBV) diseases.
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers